Interestingly, a recent study reported that desuccinylation mediated by SIRT5 is an indispensable event for histidine combination therapy against 6-mercaptopurine resistance in pediatric patients with B-ALL (11). The gene discussed is SIRT5; the disease is acute lymphoblastic leukemia.